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Osteoarticular brucellosis is the most common localization of human active disease. Osteocytes are the most abundant cells of
bone. They secrete factors that regulate the differentiation of both osteoblasts and osteoclasts during bone remodeling. The aim
of this study is to determine if Brucella abortus infection modifies osteocyte function. Our results indicate that B. abortus infec-
tion inducedmatrix metalloproteinase 2 (MMP-2), receptor activator for NF-B ligand (RANKL), proinflammatory cytokines,
and keratinocyte chemoattractant (KC) secretion by osteocytes. In addition, supernatants from B. abortus-infected osteocytes
induced bone marrow-derived monocytes (BMM) to undergo osteoclastogenesis. Using neutralizing antibodies against tumor
necrosis factor alpha (TNF-) or osteoprotegerin (OPG), RANKL’s decoy receptor, we determined that TNF- and RANKL are
involved in osteoclastogenesis induced by supernatants from B. abortus-infected osteocytes. Connexin 43 (Cx43) and the integ-
rins E11/gp38, integrin-, integrin-, and CD44 are involved in cell-cell interactions necessary for osteocyte survival. B. abortus
infection inhibited the expression of Cx43 but did not modify the expression of integrins. Yet the expression of both Cx43 and
integrins was inhibited by supernatants from B. abortus-infected macrophages. B. abortus infection was not capable of inducing
osteocyte apoptosis. However, supernatants from B. abortus-infected macrophages induced osteocyte apoptosis in a dose-de-
pendent manner. Taken together, our results indicate that B. abortus infection could alter osteocyte function, contributing to
bone damage.
Brucella spp. are Gram-negative facultative intracellular bacte-ria that cause a debilitating and chronic zoonotic disease (1).
Osteoarticular complications are important due to their high
prevalence and also to the associated functional sequelae (2–4).
Bone loss has been consistently reported in the three most fre-
quent forms of osteoarticular brucellosis (sacroiliitis, spondylitis,
and peripheral arthritis) (5–8).
Although the ability of Brucella to cause bone loss is well doc-
umented, the molecular mechanisms implicated have not been
completely deciphered yet. We have recently described a putative
immune mechanism for inflammatory bone loss that may occur
in response to infection by B. abortus. Our results revealed an
important contribution of the macrophages, osteoblasts, and T
lymphocytes in response to B. abortus infection and the resulting
induction of osteoclast differentiation (9–11).
For many years the bone-bound osteocyte has been considered
a relatively inactive cell with a broadly unknown role in the bone.
But osteocytes are not only the most abundant bone cells and
comprise up to 95% of the bone cells in the adult skeleton but also
the central regulators of the differentiation and activity of both
osteoblasts and osteoclasts during bone remodeling (12). Primary
osteocytes and the osteocyte cell line MLO-Y4 secrete macrophage
colony-stimulating factor (M-CSF) and RANKL, both necessary
for osteoclast formation (13), and recent studies showed that os-
teocytes are the major regulators of osteoclast formation and ac-
tivation (14). In addition to the role of osteocytes in regulating
bone remodeling, emerging evidence suggests an important role
for the gap junction in osteoclast-osteocyte communication (15).
Connexin 43 (Cx43) is the most prominent gap junction protein
expressed in osteocytes (15), and deficient mice have increased
bone resorption and osteoclast numbers (16, 17). In vitro studies
revealed that Cx43-deficient MLO-Y4 cells display an increase in
the RANKL/osteoprotegerin (OPG) ratio compared to control
MLO-Y4 cell levels, indicating that loss of Cx43 in osteocytes pro-
motes osteoclastogenesis (17, 18). On the other hand, it has been
reported that mice lacking Cx43 in osteoblasts/osteocytes or only
in osteocytes exhibit increased osteocyte apoptosis (18). More-
over, integrins can link the cellular cytoskeletal network to the
extracellular matrix (19). Integrins are essential determinants of
cell survival, and, in many cases, prevention or alteration of integ-
rin adhesion triggers a form of apoptosis known as anoikis (20). In
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this way osteocyte cell death has been shown to be important for
disease progression and bone loss (21).
We have previously demonstrated that Brucella spp. can infect
and survive within human osteoblasts and that this infection elic-
its the secretion of RANKL, proinflammatory cytokines, and
chemokines that might be involved in the osteoarticular manifes-
tations of brucellosis. Such a response was further amplified by
subsequent interactions between osteoblasts and monocytes in
the face of B. abortus infection (9, 10). Then, B. abortus infection
might create a microenvironment that would promote alterations
of osteocyte biology. This could have an important contribution
in the bone damage observed in patients with osteoarticular bru-
cellosis.
MATERIALS AND METHODS
Bacterial culture. Brucella abortus S2308 and its isogenic virB10 mutant
were grown overnight in 10 ml of tryptic soy broth (Merck, Buenos Aires,
Argentina) with constant agitation at 37°C. Bacteria were harvested, and
the inocula were prepared as described previously (10). All live-Brucella
manipulations were performed in biosafety level 3 facilities located at the
Instituto de Investigaciones Biomédicas en Retrovirus y SIDA.
Cellular infection. The MLO-Y4 cell line, kindly provided by Lynda
Bonewald (University of Missouri—Kansas City), was infected with B.
abortus at different multiplicities of infection (MOIs); J774. A1 cells were
infected at an MOI of 100. After the bacterial suspension was dispensed,
the plates were centrifuged for 10 min at 2,000 rpm and then incubated for
2 h at 37°C under a 5% CO2 atmosphere. Cells were extensively washed
with Dulbecco’s modified Eagle’s medium (DMEM) to remove extracel-
lular bacteria and incubated in medium supplemented with 100g/ml of
gentamicin and 50 g/ml of streptomycin to kill extracellular bacteria.
MLO-Y4 cells were harvested at different times (see below) to deter-
mine intracellular replication, cytokine production, matrix metallopro-
teinase (MMP) secretion, Cx43, E11/gp38, integrin- and -, and CD44
expression, and apoptosis and to obtain culture supernatants to perform
osteoclastogenesis assays. Supernatants from J774.A1 cells were harvested
at 24 h postinfection (p.i.) to be used as conditioned medium.
Zymography. Gelatinase activity was assayed as described previously
(10, 22).
Measurement of cytokine concentrations. Secretion of interleu-
kin-1 (IL-1), IL-6, IL-8, tumor necrosis factor alpha (TNF-), and
monocyte chemotactic protein 1 (MCP-1) was quantified by enzyme-
linked immunosorbent assays (ELISAs) (BD Biosciences) of culture su-
pernatants.
Apoptosis assays. MLO-Y4 cells were infected at different MOIs; 24 h
after infection cells were washed, and the percentage of apoptotic cells
was assessed by annexin V-fluorescein isothiocyanate (FITC) and pro-
pidium iodide (PI) (BD) for 10 min on ice. Apoptosis was analyzed on a
FACSCalibur flow cytometer. Data were processed using FlowJo software
(Tree Star). Apoptosis was also assessed quantitatively either by a terminal
deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL)
assay using a fluorescein FragEL DNA fragmentation detection kit (Cal-
biochem, San Diego, CA), by Hoechst dye 33342 (which visualized nu-
clear morphology), or by annexin V-FITC/PI by reseeding osteocytes on
Permanox chamber slides (Nunc, Roskilde, Denmark). As a positive con-
trol, cells were treated with H2O2 (200 M).
Stimulation with conditioned medium. Culture supernatants from
B. abortus-infected J774.A1 macrophage cells were harvested at 24 h p.i.,
sterilized by filtration through a 0.22-m-pore-size nitrocellulose filter,
and used to stimulate noninfected MLO-Y4 cells. Supernatants were used
diluted 1/2, 1/5, or 1/10 in complete medium. After 24 h the cells were
harvested to determine Cx43, E11/gp38, integrin- and -, tubulin-,
and CD44 expression and apoptosis.
Osteoclast formation assay. Bone marrow-derived monocytes
(BMM) were induced to undergo osteoclastogenesis as described previ-
ously (23). Briefly, bone marrow cells from BALB/c mice were cultured in
complete medium containing 5 ng/ml murine recombinant M-CSF (rM-
CSF) (R&D Systems, Minneapolis, MN, USA) for 12 h in 24-well plates.
Nonadherent cells were harvested and cultured with 30 ng/ml M-CSF in
24-well plates for an additional 24 h. Nonadherent cells were washed out,
and adherent cells were collected and used as BMM (5  104 cells/well),
which were seeded onto glass coverslips in 24-well plates for 7 days and
cultured in complete medium containing 30 ng/ml M-CSF and 0.2 ml of
culture supernatants from MLO-Y4 osteocytes infected with B. abortus.
As positive controls of osteoclast formation, BMM cultures received 50
ng/ml murine TNF- or RANKL. On day 3, the culture medium and all
reagents were replaced. To identify osteoclasts, cells were fixed in 4%
paraformaldehyde and stained for tartrate-resistant acid phosphatase
(TRAP) (Sigma-Aldrich, St. Louis, MO, USA). TRAP-positive, multinu-
cleated (more than three nuclei) cells were defined as osteoclasts, and the
number was determined by microscopic counts.
Immunofluorescence. B. abortus-infected MLO-Y4 cells or MLO-Y4
cells treated with supernatants from B. abortus-infected J774.A1 macro-
phages were fixed in 3% paraformaldehyde for 10 min at room tempera-
ture and permeabilized with 0.3% Triton X-100 for 10 min. Cells were first
incubated with mouse anti-Cx43 (Invitrogen) diluted in phosphate-buff-
ered saline (PBS)– 0.1% Tween for 30 min and then with Alexa 488 anti-
mouse (Invitrogen). DAPI (4=,6=-diamidino-2-phenylindole) was used
for nuclear staining for 30 min. After cells were washed in PBS, they were
mounted and analyzed by fluorescence microscopy.
mRNA preparation and quantitative reverse transcription-PCR
(qRT-PCR). RNA was extracted using a Quick-RNA MiniPrep Kit (Zymo
Research), and 1 g of RNA was subjected to reverse transcription using
Improm-II reverse transcriptase (Promega). PCR analysis was performed
with an Mx3000P real-time PCR detection system (Stratagene) using
SYBR green as a fluorescent DNA binding dye. The primer sets used for
amplification were as follows: Cx43 sense, 5=-TACCACGCCACCACCG
GCCCA, and antisense, 5=-GGCATTTTGGCTGTCGTCAGGGAA; E11/
gp38 sense, 5=-CGACCAGTTTCTAACACCTGCCTTCT, and antisense,
5=-CTGTCCCAGCAACACTGAGTCCC; integrin- sense, 5=-GAATGG
CGAAGGAAACTCTGAAA, and antisense, 5=-ATAAACTGAGACTGCT
GGGTGCT; integrin- sense, 5=-CCACCTTCACCAATATCAC, and an-
tisense, 5=-CCAAATCCCACCCATACAC; CD44 sense, 5=-GGATTCATC
CCAACGCTAT, and antisense, 5=-ACTCGCCCTTCTTGCTGT; -actin
sense, 5=-AACAGTCCGCCTAGAAGCAC, and antisense, 5=-CGTTGAC
ATCCGTAAAGACC.
The amplification cycle consisted of 95°C for 30 s, 55°C for 30 s, and
72°C for 60 s. All primer sets yielded a single product of the correct size.
Relative expression levels were normalized against the level of -actin.
Statistical analysis. Statistical analysis was performed with one-way
analysis of variance (ANOVA), followed by a post hoc Tukey test using
GraphPad Prism, version 4.0, software. Data are represented as means
standard deviations (SD).
RESULTS
B. abortus invades andmultiplies in osteocytes. Infection exper-
iments showed that Brucella abortus is internalized by murine os-
teocytes (MLO-Y4 cell line) in vitro. Follow-up of infected cul-
tures revealed that B. abortus can replicate inside murine
osteocytes. The magnitude of infection (intracellular CFU) in-
creased by about 1 log during the first 48 h p.i., and then the
number of intracellular bacteria was maintained during the next
24 h. As a control, J774.A1 cells, a macrophage cell line that was
consistently reported to support Brucella infection and growth,
were infected in parallel. At any time tested, the number of bacte-
ria was higher in J774.A1 cells than in MLO-Y4 cells (Fig. 1A). This
is a consistent result because it has been reported that macro-
phages are the preferential cells that support Brucella replication
(24, 25).
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B. abortus-infected osteocytes secrete proinflammatory me-
diators. Several soluble mediator/effector molecules have been
implicated in bone resorption. RANKL, MMP-2, and proinflam-
matory cytokines such as TNF-, IL-1, and IL-6 have been
shown to be important (26–28). In addition, chemokines could
contribute to bone damage by attracting inflammatory cells to the
sites of infection that secrete inflammatory cytokines. Thus, we
decided to investigate the ability of mouse MLO-Y4 osteocytes to
secrete cytokines, chemokines, and MMPs upon infection with B.
abortus. B. abortus infection of MLO-Y4 osteocytes elicited a sig-
nificant secretion of MMP-2, RANKL, TNF-, IL-6, and kerati-
nocyte chemoattractant (KC) in an MOI-dependent manner (Fig.
1B to F). However, B. abortus-infected MLO-Y4 osteocytes were
unable to secrete IL-1 (data not shown). Altogether, these results
indicate that B. abortus can infect and replicate in osteocytes, and,
as a result of this infection, proinflammatory mediators are se-
creted.
B. abortus infection reduced Cx43 expression but did not
modify the expression of E11/gp38, integrin- and -, and
CD44. Cx43 is the predominant gap junction protein in bone
cells. It facilitates the communication of cellular signals between
cells that are required to maintain viability of osteocytes (18). To
determine if B. abortus infection could modulate Cx43 expression
in osteocytes, these cells were infected with B. abortus; then the
expression of the Cx43 gene was determine by qRT-PCR, and
Cx43 protein expression was assessed by immunofluorescence us-
ing specific antibodies. B. abortus infection reduced Cx43 expres-
sion in a time-dependent fashion (Fig. 2A and B), indicating that
the infection could alter the gap junction in osteocytes. On the
other hand, integrins can link the cellular cytoskeletal network to
the extracellular matrix (19), and they are essential determinants
of cell survival (20). Therefore, experiments were conducted to
determine whether B. abortus infection could affect the expression
of integrins. Our results indicated that B. abortus infection did not
modify mRNA expression of E11/gp38, integrin- and -, and
CD44 (data not shown).
Culture supernatants fromB. abortus-infectedmacrophages
inhibit Cx43 and integrin expression in osteocytes. Macro-
phages secrete proinflammatory cytokines upon infection with B.
abortus (29, 30). These cytokines may have different effects on
Cx43 and integrin expression (31–34). Thus, we decided to inves-
tigate the effect of cytokines present in supernatants from B. abor-
tus-infected macrophages on Cx43 and integrin expression. To
this end, supernatants from B. abortus-infected J774.A1 macro-
phages were harvested at 24 h p.i., sterilized by filtration, and used
at 1/2 dilutions to stimulate osteocytes. Culture supernatants from
B. abortus-infected macrophages inhibited the mRNA expression
of CD44 and integrin- and - and, to a lower extent, the mRNA
expression of E11/gp38 (Fig. 3A to D). They also inhibited mRNA
and protein expression of Cx43 (Fig. 3E and F). The magnitude of
inhibition was higher at 48 h posttreatment for all molecules ex-
cept for CD44, which showed greater inhibition at 24 h and the
expression of which was restored at 48 h posttreatment. Superna-
tants from noninfected macrophages had no effect on the expres-
sion of these molecules.
Taking into account that Cx43 and integrins are involved in
sensing and signaling mechanisms in response to mechanical
forces, osteoclast differentiation, osteoclast migration, apoptosis
of osteocytes, and MMP secretion (35–37), these results suggest
FIG 1 B. abortus invades and multiplies in murine osteocytes cells, inducing MMP-9 and cytokine secretion. (A) Osteocytes (MLO-Y4 cell line) and monocytes
(J774.A1 cell line) were infected with B. abortus at an MOI of 100, and replication in each cell type was assessed by determining CFU counts after 2, 4, 24, 48, and
72 h. (B) MLO-Y4 cells were infected with B. abortus at different MOIs, and 24 h after infection MMP-9 production was determined by zymography. (C to F)
Levels of RANKL, the cytokines TNF- and IL-6, and KC, as indicated, were evaluated by ELISA in culture supernatants harvested at 24 h (RANKL, IL-6, and KC)
or 8 h (TNF-) postinfection. PMA, phorbol myristate acetate. Data are given as the means SD from at least three individual experiments. *, P 0.1; **, P
0.01; ***, P 0.001, for results versus noninfected (NI) cells.
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that macrophage infection could alter bone homeostasis by mod-
ulating Cx43 and integrin expression in osteocytes.
B. abortus infection does not induce apoptosis of osteocytes,
but it is induced by supernatants fromB. abortus-infectedmac-
rophages. It has been reported that mice lacking Cx43 in osteo-
blasts/osteocytes or only in osteocytes exhibit increased osteocyte
apoptosis (18). Taking into account that B. abortus induced a re-
duction in Cx43 expression, we decided to investigate whether B.
abortus infection induces osteocyte apoptosis. To this end, osteo-
cytes were infected with B. abortus, and the presence of apoptotic
cells was determined by annexin V-FITC and propidium iodide
staining, TUNEL assay, and Hoechst 33342 staining. Our results
indicated that B. abortus infection did not induce osteocyte apop-
tosis at any MOI tested (data not shown). These results indicated
that, by itself, the reduction in the expression of Cx43 induced by
B. abortus infection was not sufficient to induce apoptosis in os-
teocytes. On the other hand, Brucella could also modulate apop-
totic and antiapoptotic factors during osteocyte infection as oc-
curs in macrophages and synovial fibroblast infection (38, 39). Yet
integrins are also involved in promoting cell viability (20). Since
supernatants from B. abortus-infected macrophages inhibited the
expression of these molecules, experiments were conducted to
determine whether supernatants from B. abortus-infected macro-
phages induce osteocyte apoptosis. To this end, MLO-Y4 cells
were stimulated with a 1/2 dilution of supernatants from B. abor-
tus-infected J774.A1 macrophages or supernatants from unin-
FIG 2 B. abortus infection reduced Cx43 expression in osteocytes. (A) Relative expression of the Cx43 gene was assessed by qRT-PCR in noninfected (NI) and
B. abortus (Ba)-infected MLO-Y4 cells. (B) Cx43 was revealed by immunofluorescence with a specific antibody at 48 h postinfection. Data are given as the
means SD from at least three individual experiments. Data shown are from a representative experiment of three performed. ***, P 0.001, versus results in
noninfected cells.
FIG 3 Supernatants from B. abortus-infected macrophages inhibit Cx43 and integrin expression in osteocytes. MLO-Y4 cells were stimulated with supernatants
(added at a 1:2 proportion) from noninfected (NI) or B. abortus-infected macrophages (murine J774.A1 cell line), and the relative expression levels of the of
E11/gp38 (A), integrin- (B), integrin- (C), CD44 (D), and Cx43 (E) genes were assessed by qRT-PCR at 24 and 48 h poststimulation. (F) Cx43 production was
revealed by immunofluorescence with a specific antibody at 48 h poststimulation. Data are given as the means SD from at least three individual experiments.
**, P 0.01; ***, P 0.001, versus results in noninfected cells. CS, culture supernatant.
Pesce Viglietti et al.












fected macrophages as a control. After 24 h cells were stained with
annexin V-FITC and analyzed by flow cytometry. Osteocytes
stimulated with supernatants from B. abortus-infected macro-
phages exhibited significantly higher annexin V-FITC binding
than cells treated with supernatants from uninfected macrophages
or untreated cells (Fig. 4A), suggesting a proapoptotic effect of
Brucella-infected supernatants. The occurrence of apoptosis was
confirmed by Hoechst 33342 staining (Fig. 4B and C) and TUNEL
assay (Fig. 4B and D). These results indicated that supernatants
from B. abortus-infected macrophages induce osteocyte apopto-
sis, contributing in this way to bone loss.
Supernatants from B. abortus-infected osteocytes induce
BMM-derived osteoclastogenesis. Osteoclasts play an important
role in bone resorption and originate from fusion of precursor
cells that belong to the monocyte macrophage linage in the bone
marrow (40, 41). This process is mediated by RANKL, but under
inflammatory conditions it could be mediated by proinflamma-
tory cytokines in conjunction with M-CSF (23). To determine if
factors produced by B. abortus-infected osteocytes could induce
osteoclast formation from BMM, these cells were stimulated with
M-CSF in conjunction with supernatants from osteocytes infected
with B. abortus, and osteoclastogenesis was determined by the
generation of multinucleated TRAP-expressing cells. The forma-
tion of osteoclast-like cells was induced by supernatants from B.
abortus-infected MLO-Y4 cells in a dose-dependent manner but
not by those from uninfected cells (Fig. 5). These results indicate
that infection of osteocytes with B. abortus promotes osteoclast
formation.
Supernatant from B. abortus wild-type- or virB10 mutant-
infected osteocytes induces osteoclastogenesis in a mechanism
dependent on the presence of RANKL and TNF-. RANKL and
TNF- are abundant in sites of inflammatory bone erosion (42).
Because these cytokines are potent osteoclastogenic factors and
because their signaling pathways are considerably overlapping un-
der proinflammatory conditions, RANKL and TNF-might syn-
ergistically orchestrate enhanced osteoclastogenesis via coopera-
tive mechanisms (42). Since these cytokines were secreted upon
infection of MLO-Y4 cells, experiments were conducted to deter-
mine their contribution in the osteoclastogenesis induced by su-
pernatants from B. abortus-infected MLO-Y4 cells. To this end,
BMM cells were cultured with M-CSF and supernatants from B.
abortus-infected MLO-Y4 cells in the presence of anti-TNF- an-
tibody or OPG, a RANKL decoy receptor, and osteoclastogenesis
was evaluated by the generation of TRAP-expressing cells. Com-
pared with untreated cells, TNF- neutralizing antibody signifi-
cantly reduced osteoclastogenesis induced by supernatants from
Brucella-infected MLO-Y4 osteocytes. In addition, OPG also re-
duced the formation of osteoclast-like cells. As expected, RANKL
and TNF- induced TRAP expression in cells (see Fig. 7).
Since the type four secretion system (T4SS) VirB from B. abor-
tus has been involved in the induction of inflammatory responses
upon infection (43, 44), experiments were conducted to deter-
mine the role of the T4SS in the secretion of TNF-, IL-6, and
RANKL by osteocytes. To this end, MLO-Y4 osteocytes were in-
fected with B. abortus or the isogenic mutant virB10 strain, and the
B. abortus virB10 mutant was unable to induce significant levels of
FIG 4 Supernatants from B. abortus-infected macrophages induce apoptosis of osteocytes. MLO-Y4 cells were treated with supernatants (added at a 1:2
proportion) from noninfected (NI) or B. abortus-infected macrophages (J774.A1 cell line), and 24 h after stimulation apoptosis was evaluated by annexin V/PI,
TUNEL, and Hoechst 33342 assays. (A) Flow cytometry analysis of apoptotic cells by annexin V/PI. (B) Hoechst 33342 staining and TUNEL assays using
fluorescence microscopy. (C and D) Quantitative analysis of experiments presented in panel B. H2O2 (200 M) was used as a positive control. NT, nontreated
cells. Data are given as the means SD from at least three individual experiments. *, P 0.1; **, P 0.01; ***, P 0.001, versus results in noninfected cells.
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TNF- secretion (Fig. 6A and B). However, levels of RANKL (Fig.
6C, D, E, and F) produced by the virB10 mutant were comparable
at all MOIs to the levels induced by the B. abortus wild-type strain.
In contrast to the levels of IL-6 observed in macrophages (44), the
B. abortus virB10 mutant induced higher levels of IL-6 than the
wild type. Together, these results indicate that B. abortus induces
TNF- secretion by a mechanism that is dependent on a func-
tional T4SS. Since under inflammatory conditions TNF- is the
key proinflammatory cytokine involved in osteoclastogenesis (45,
46), experiments were conducted to determine the role of the
T4SS in osteoclastogenesis induction. To this end, supernatants
from B. abortus virB10 mutant-infected osteocytes were used to
determine osteoclast differentiation from BMM in the presence of
M-CSF. Our results indicated that supernatants from virB10 mu-
tant-infected osteocytes, which do not induce TNF- secretion,
were able to induce osteoclast differentiation from BMM at a de-
gree similar to that induced by supernatants from B. abortus wild-
type-infected osteocytes. When osteoclastogenesis experiments
were performed in the presence of OPG, osteoclastogenesis in-
duced by supernatants from virB10 mutant-infected osteocytes
was abrogated (Fig. 7).
Taken together, these results indicated that both RANKL and
TNF- contribute to the generation of osteoclast-like cells.
DISCUSSION
Osteoarticular brucellosis is the most common presentation of
human active brucellosis disease (5, 7, 47–49). In this paper, we
studied the role played by osteocytes in this form of the disease as
they are the most abundant cells in the bone (12). Yet their func-
tional role was unknown for a long time. In part, it is because
osteocytes are deeply embedded in the mineralized bone matrix
and are not readily accessible for many experimental approaches.
The establishment of the osteocyte-like cell line MLO-Y4 has
made experiment possible because these cells have been shown to
have characteristics of primary osteocytes (50). In this paper, we
studied the role played by osteocytes in osteoarticular brucellosis
as they have been recognized as central mediators involved in
osteoblast and osteoclast homeostasis that is disrupted in inflam-
matory bone disease of either infectious or noninfectious origin
(51).
We demonstrate that B. abortus may invade and replicate in
osteocytes. The ability of B. abortus to invade, survive, and repli-
cate within osteocytes is in line with its capacity to replicate in
other nonphagocytic cells, including hepatocytes, astrocytes, sy-
noviocytes, and osteoblasts (10, 52–54). Our results also indicate
thatB. abortus infection induces the secretion of MMP-2, RANKL,
and proinflammatory cytokines. Increases in MMP levels may
cause tissue damage. Indeed, locally increased levels of MMP have
been found in several osteoarticular diseases, including rheumatic
conditions (rheumatoid arthritis, osteoarthritis, and spondyloar-
thritis) and infectious arthritis such as that observed in Lyme dis-
ease (55–57). Furthermore, RANKL is a homotrimeric molecule
displayed on the membrane of osteoblasts that stimulates differ-
entiation of osteoclasts and is a key molecule involved in bone
resorption and, under pathological conditions, increased expres-
sion levels, leading to bone destruction (58). In addition, proin-
flammatory cytokines could contribute to bone damage, inducing
osteoclastogenesis (26, 27, 59–61). In chronic inflammatory bone
diseases, such as rheumatoid arthritis, the proinflammatory cyto-
kines TNF-, IL-1, and IL-6 have been shown to be important
FIG 5 Supernatants from B. abortus-infected osteocytes induce BMM-derived osteoclastogenesis. BMM cells were either not treated (NT) or stimulated with
culture supernatants (CS) from B. abortus-infected MLO-Y4 cells (added at a 1:2, 1:5, or 1:10 proportion) or with culture supernatants from noninfected (NI)
MLO-Y4 cells (added at a 1:2 proportion) in conjunction with M-CSF. After 7 days, osteoclastogenesis was determined by the generation of multinucleated
TRAP-positive cells. Representative digital images were taken by light microscopy (A), and multinucleated TRAP-positive cells were identified and counted (B).
RANKL was used as a positive control. Data are given as the means SD from at least three individual experiments. **, P 0.01; ***, P 0.001, versus results
in noninfected cells.
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for disease progression and osteoclastogenesis (23, 26, 27, 59–61).
Our results using the neutralizing antibody anti-TNF- and OPG
indicate that RANKL and TNF- are both the key cytokines in-
volved in osteoclastogenesis induced by B. abortus-infected osteo-
cytes. In addition, TNF- secretion was shown to be dependent on
the expression of a functional T4SS. This secretion system has
been reported previously to be involved in the inflammatory re-
sponse induced by B. abortus infection (43, 44).
Channels formed by Cx43, the most abundant member of the
connexin family of proteins expressed in bone cells, mediate the
communication among osteocytes and between osteocytes and
cells on the bone surface (62). Cx43 deletion in cultured osteocytic
cells resulted in increased apoptosis (18). Integrins also control
the fate and function of cells by influencing not only their prolif-
eration and differentiation but also apoptosis (63). B. abortus in-
fection reduced the expression of Cx43 expression but did not
modify integrin expression, which resulted in the absence of apop-
tosis. However, taking into account that monocytes/macrophages
are the main replication niche for Brucella, experiments were con-
ducted to determine whether B. abortus-infected macrophages
could modulate Cx43 and integrin expression in osteocytes. Su-
pernatants from B. abortus-infected macrophages significantly re-
duced the expression of Cx43 and integrins, with concomitant
apoptotic cell death.
Based on the results obtained in the present study, we hypoth-
esize that B. abortus may harm osteocyte function and viability
FIG6 B. abortus virB10mutant does not induce TNF- secretion by osteocytes. Levels of TNF- (A and B), RANKL (C and D), and IL-6 (E and F) were measured
in culture supernatants from noninfected (NI) and B. abortus (Ba)-infected or B. abortus virB10 mutant (	virB10)-infected MLO-Y4 cells by ELISA at 24 and 48
h postinfection. PMA, phorbol myristate acetate. Data are given as the means SD from at least three individual experiments. *, P 0.1; **, P 0.01; ***, P
0.001, versus results in noninfected cells.
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directly and indirectly, contributing to the bone and joint destruc-
tion observed in patients with osteoarticular complications of
brucellosis.
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